Intrauterine Growth Restriction: Diagnosis and Management

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/18

flashcard set

Earn XP

Description and Tags

Vocabulary flashcards covering the etiology, classification, diagnostic methods, Doppler parameters, and clinical management strategies for intrauterine growth restriction (IUGR) and small for gestational age (SGA) fetuses.

19 Terms

1
New cards

Small for gestational age (SGA)

A heterogeneous clinical classification referring to fetuses or neonates whose measurements fall below expected percentiles (commonly defined as <10th centile<10\text{th}\text{ centile}, with <3rd to 5th centile<3\text{rd}\text{ to }5\text{th}\text{ centile} carrying the greatest risk of adverse perinatal outcomes), encompassing constitutionally small fetuses, chromosomal or structural defects, intrauterine infections, and true growth restriction.

2
New cards

Intrauterine growth restriction (IUGR)

A pathological condition and subset of SGA resulting from an inadequacy in the supply of nutrients and/or oxygen to the fetus through the uteroplacental unit, preventing the fetus from reaching its genetically determined growth potential and increasing risks of perinatal morbidity, mortality, and adult degenerative diseases.

3
New cards

Constitutionally small fetus

A healthy fetus of small stature that accounts for 80–85%80\text{--}85\% of all SGA fetuses in accurately dated pregnancies, exhibiting a symmetric growth rate parallel to normal curves, normal anatomical structures, normal amniotic fluid volume, and normal umbilical artery Doppler findings.

4
New cards

Customised antenatal growth charts

Growth assessment curves adjusting for physiological maternal variables—specifically maternal height, booking weight, parity, and ethnic group—that plot weeks of gestation on the x-axisx\text{-axis} against symphysis fundal height or ultrasound-derived fetal weight on the y-axisy\text{-axis} to reduce false-positive and false-negative misclassifications of growth disorders.

5
New cards

Early onset SGA (Symmetric growth restriction)

Growth restriction presenting in the early stages of pregnancy (cellular hyperplasia phase, before 16 to 32 weeks16\text{ to }32\text{ weeks}), resulting in a proportionate reduction across all fetal organs; primary etiologies include severe maternal vascular disease, chromosomal or structural anomalies, and congenital infections.

6
New cards

Late onset SGA (Asymmetric growth restriction)

Growth restriction presenting after 32 weeks32\text{ weeks} of gestation during the cellular hypertrophy phase, primarily caused by uteroplacental dysfunction and characterized by a disproportionate reduction in abdominal circumference relative to head circumference and length.

7
New cards

Brain-sparing effect

A compensatory hemodynamic adaptation in late-onset fetal hypoxaemia whereby blood flow is redistributed to vital organs (the brain, heart, and placenta) and away from the viscera, maintaining head circumference while reducing liver size and subcutaneous abdominal fat.

8
New cards

TORCH infections

A group of congenital fetal infections—notably toxoplasmosis, rubella, cytomegalovirus, varicella, and HIV—that impair early cellular hyperplasia, causing early symmetric growth restriction.

9
New cards

Insulin-like growth factor 1 receptor (IGF-1R) gene mutation

A genetic mutation causing disordered function of IGF-1 receptors, which has been identified as a cause of restricted intrauterine fetal growth and suboptimal postnatal physical development.

10
New cards

Symphysis fundal height (SFH) measurement

A clinical screening procedure where the clinician positions the patient supine with legs extended and bladder empty, palpates the fundus caudally from the xiphisternum, and measures the distance to the upper border of the pubic symphysis using a non-elastic tape laid scale-face-down along the uncorrected uterine axis.

11
New cards

Abdominal circumference (AC)

An ultrasound biometry measurement assessing fetal liver volume and glycogen storage, directly reflecting fetal nutritional status; a value <10th centile<10\text{th}\text{ centile} on customised charts provides high sensitivity for detecting IUGR, whereas a normal value has a high negative predictive value.

12
New cards

Growth velocity

The rate of anatomical change and fetal weight gain measured over serial ultrasound examinations (typically separated by at least 2 weeks2\text{ weeks}), recognized as the single most sensitive indicator of fetal growth.

13
New cards

Umbilical artery (UA) Doppler

An ultrasound surveillance modality used to assess vascular resistance in the fetoplacental circulation; uteroplacental insufficiency causes reduced diastolic flow and an increased systolic/diastolic flow ratio.

14
New cards

Absent or reversed end-diastolic flow (A/RED)

A severe umbilical artery Doppler abnormality signifying critical downstream vascular resistance; before 34 weeks34\text{ weeks}, it requires maternal admission, antenatal corticosteroids, and intensive monitoring, while at ≥34 weeks\ge 34\text{ weeks} or alongside abnormal biophysical profile findings, it indicates expedited delivery.

15
New cards

Pulsatile umbilical venous flow

An advanced hemodynamic abnormality detected via venous Doppler studies indicating severe fetal acidaemia, impending decompensation, and an elevated risk of intellectual impairment and perinatal death.

16
New cards

Amniotic fluid index (AFI)

An ultrasound measurement assessing amniotic fluid volume, where reduced volume or oligohydramnios (AFI<5 cm\text{AFI} < 5\,\text{cm} or a single deepest vertical pocket <2 cm< 2\,\text{cm}) is strongly linked to increased perinatal mortality and indicates the need to expedite delivery.

17
New cards

Biophysical profile (BPP)

A composite assessment tool evaluating fetal dynamic activities and cardiotocography; although not recommended for routine low-risk screening, it provides a high negative predictive value in evaluating fetal wellbeing when umbilical artery Doppler flow is abnormal.

18
New cards

Growth Restriction Intervention Trial (GRIT)

A landmark clinical trial concluding that at gestations less than 31 weeks31\text{ weeks}, delivery is best delayed if there is clinical uncertainty regarding intervention, showing that early delivery does not reduce adverse neurological or survival outcomes.

19
New cards

Alpha-fetoprotein (AFP) screening

A biochemical serum marker which, when found to be elevated in the absence of fetal structural anomalies, correlates with a 5–10×5\text{--}10\times increased risk of developing IUGR later in pregnancy.